Stockreport

Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer

Vir Biotechnology, Inc.  (VIR) 
PDF - Astellas and Vir Biotechnology to co-develop and co-commercialize VIR-5500 through a sharing of expenses and revenues- Astellas to lead commercialization of VIR-5500 i [Read more]